DK1083175T3 - Triazolderivater med antifugal aktivitet - Google Patents

Triazolderivater med antifugal aktivitet

Info

Publication number
DK1083175T3
DK1083175T3 DK00307799T DK00307799T DK1083175T3 DK 1083175 T3 DK1083175 T3 DK 1083175T3 DK 00307799 T DK00307799 T DK 00307799T DK 00307799 T DK00307799 T DK 00307799T DK 1083175 T3 DK1083175 T3 DK 1083175T3
Authority
DK
Denmark
Prior art keywords
triazole derivatives
antifugal
activity
antifugal activity
triazole
Prior art date
Application number
DK00307799T
Other languages
English (en)
Inventor
Toshiyuki Konosu
Sadao Oida
Makoto Mori
Takuya Uchida
Satoshi Ohya
Akihiko Nakagawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK1083175T3 publication Critical patent/DK1083175T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00307799T 1999-09-09 2000-09-08 Triazolderivater med antifugal aktivitet DK1083175T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25570299 1999-09-09
JP2000103826 2000-04-05

Publications (1)

Publication Number Publication Date
DK1083175T3 true DK1083175T3 (da) 2003-10-06

Family

ID=26542380

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00307799T DK1083175T3 (da) 1999-09-09 2000-09-08 Triazolderivater med antifugal aktivitet

Country Status (23)

Country Link
US (3) US6391903B1 (da)
EP (1) EP1083175B1 (da)
KR (1) KR100592201B1 (da)
CN (1) CN1167700C (da)
AR (1) AR025610A1 (da)
AT (1) ATE244238T1 (da)
AU (1) AU778073B2 (da)
BR (1) BR0004066A (da)
CA (1) CA2317691C (da)
DE (1) DE60003618T2 (da)
DK (1) DK1083175T3 (da)
ES (1) ES2200786T3 (da)
HK (1) HK1034259A1 (da)
HU (1) HU224699B1 (da)
ID (1) ID27234A (da)
IL (1) IL138329A0 (da)
NO (1) NO318352B1 (da)
NZ (1) NZ506818A (da)
PT (1) PT1083175E (da)
RU (1) RU2203280C2 (da)
SA (1) SA00210602B1 (da)
TR (1) TR200002610A3 (da)
TW (1) TW530057B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI334866B (en) 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
BRPI0411043A (pt) * 2003-06-06 2006-07-11 Sankyo Co composição medicinal
PL1954264T3 (pl) 2005-12-01 2010-02-26 Basilea Pharmaceutica Ag Sposób wytwarzania epoksybutanolowych związków pośrednich
CL2008000231A1 (es) 2007-01-29 2008-05-30 Eisai R&D Man Co Ltd Forma solida de (8e,12e,14e)-7-((4-cicloheptilpiperazin-1-il)carbonil)oxi-3,6,16,21-tetrahidroxi-6,10,12,16,20-pentametil-18,19-epoxitricosa-8,12,14-trien-il-olido; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8322983D0 (en) * 1983-08-26 1983-09-28 Pfizer Ltd Triazole antifungal agents
US4483863A (en) * 1984-01-20 1984-11-20 Pfizer Inc. Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
TW198027B (da) * 1990-08-26 1993-01-11 Sankyo Co
KR100367327B1 (ko) 1995-04-06 2003-03-03 상꾜 가부시키가이샤 트리아졸항진균제
JP2902345B2 (ja) 1995-04-06 1999-06-07 三共株式会社 トリアゾール抗真菌剤
EP0780380B1 (en) * 1995-12-22 2001-06-13 Ss Pharmaceutical Co., Ltd. Triazole derivatives with antimycotic action and intermediates
JP3622882B2 (ja) 1996-10-04 2005-02-23 三共株式会社 トリアゾール誘導体を含有する医薬
WO1998033778A1 (en) 1997-02-04 1998-08-06 Sankyo Company, Limited Triazole derivatives
AU7937998A (en) 1997-07-08 1999-02-08 Sankyo Company Limited Antifungal triazole compounds
JPH1180135A (ja) 1997-07-08 1999-03-26 Sankyo Co Ltd 抗真菌トリアゾール化合物
EP1000951B1 (en) 1997-07-08 2005-03-30 Kaneka Corporation Hydrosilylation process and polymers produced by the process

Also Published As

Publication number Publication date
IL138329A0 (en) 2001-10-31
RU2203280C2 (ru) 2003-04-27
NO20004511D0 (no) 2000-09-08
ID27234A (id) 2001-03-15
NZ506818A (en) 2001-07-27
CN1291610A (zh) 2001-04-18
US6392082B1 (en) 2002-05-21
HUP0003555A2 (hu) 2002-05-29
KR20010067169A (ko) 2001-07-12
HK1034259A1 (en) 2001-10-19
TR200002610A2 (tr) 2001-06-21
KR100592201B1 (ko) 2006-06-23
NO318352B1 (no) 2005-03-07
HU224699B1 (en) 2006-01-30
DE60003618T2 (de) 2004-04-15
AU778073B2 (en) 2004-11-11
BR0004066A (pt) 2001-04-17
CA2317691C (en) 2009-02-17
US6391903B1 (en) 2002-05-21
EP1083175A3 (en) 2001-04-11
US6337403B1 (en) 2002-01-08
CA2317691A1 (en) 2001-03-09
CN1167700C (zh) 2004-09-22
SA00210602B1 (ar) 2006-06-04
TR200002610A3 (tr) 2001-06-21
PT1083175E (pt) 2003-09-30
ATE244238T1 (de) 2003-07-15
DE60003618D1 (de) 2003-08-07
EP1083175B1 (en) 2003-07-02
TW530057B (en) 2003-05-01
ES2200786T3 (es) 2004-03-16
AR025610A1 (es) 2002-12-04
NO20004511L (no) 2001-03-12
AU5657500A (en) 2001-03-15
HU0003555D0 (en) 2000-09-08
EP1083175A2 (en) 2001-03-14

Similar Documents

Publication Publication Date Title
ATE321065T1 (de) Purin-derivate
DE60002356D1 (de) Purin-derivate
NO20016109D0 (no) Purinderivater
NO20010743D0 (no) Antivirale indoloksoacetyl-piperazin-derivater
NO20021400D0 (no) Terapeutiske konazolinderivater
IS2116B (is) 4-fenyl-pyridin afleiður
ATE263748T1 (de) Admantan-derivate
DE60007697D1 (de) Triazolderivate
DE50010060D1 (de) Thiazolylamid-derivate
EE200100613A (et) 13-metüülerütromütsiini derivaadid
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
ATE257148T1 (de) Propargyletherderivate
ATE374747T1 (de) Monofluoralkylderivate
DK1154988T3 (da) Mevinolinderivater
DK1218340T3 (da) 4-hydroxybiphenylhydrazid-derivater
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
ATE293592T1 (de) Resorcinderivate
DK1178984T3 (da) 1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
DE60025348D1 (de) Ethansulfonyl-piperidin-derivate
DK1083175T3 (da) Triazolderivater med antifugal aktivitet
DE59909774D1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate